Home » Stocks » Neovasc

Neovasc Inc. (NVCN)

Stock Price: $2.34 USD -0.36 (-13.33%)
Updated Aug 10, 2020 4:00 PM EDT - Market closed
After-hours: $2.37 +0.03 (1.28%) Aug 10, 5:16 PM

Stock Price Chart

Key Info

Market Cap 36.71M
Revenue (ttm) 1.88M
Net Income (ttm) -35.13M
Shares Out 17.61M
EPS (ttm) -3.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $2.34
Previous Close $2.70
Change ($) -0.36
Change (%) -13.33%
Day's Open 2.40
Day's Range 2.24 - 2.45
Day's Volume 1,718,767
52-Week Range 1.24 - 8.65

More Stats

Market Cap 36.71M
Enterprise Value 46.99M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 17.61M
Float 6.74M
EPS (basic) -5.4
EPS (diluted) -3.39
FCF / Share -8.64
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 185,508
Short Ratio 0.35
Short % of Float 1.21%
Beta 3.03
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 19.49
PB Ratio n/a
Revenue 1.88M
Operating Income -30.05M
Net Income -35.13M
Free Cash Flow -24.22M
Net Cash -10.28M
Net Cash / Share -0.66
Gross Margin 86.74%
Operating Margin -1,595.48%
Profit Margin -1,679.30%
FCF Margin -1,285.83%
ROA -106.49%
ROE n/a
ROIC -381.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$8.67*
(270.51% upside)
Low
5.00
Current: $2.34
High
15.00
Target: 8.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220082007
Revenue2.091.755.399.519.9314.3711.757.821.551.52
Revenue Growth19.6%-67.54%-43.35%-4.2%-30.9%22.33%50.24%405.69%1.87%-
Gross Profit1.631.381.912.422.995.224.663.180.840.72
Operating Income-30.05-32.41-30.87-36.82-28.76-17.27-7.11-4.93-34.66-7.91
Net Income-35.13-108-21.63-86.49-26.73-18.15-6.75-0.35-34.26-7.83
Shares Outstanding2.800.480.080.070.050.030.030.030.01-
Earnings Per Share-5.40-76.26-265.37-1,282.10-410.00-330.00-140.00-10.00-2,940.00-1,590.00
Operating Cash Flow-23.97-22.79-139-39.79-21.28-8.06-4.68-2.04-8.48-6.44
Capital Expenditures-0.240.68-0.5167.09-2.14-1.12-1.04-0.31-0.05-0.54
Free Cash Flow-24.22-22.12-13927.29-23.43-9.18-5.72-2.35-8.53-6.98
Cash & Equivalents5.299.2417.5192.9555.0315.543.405.862.553.29
Total Debt15.5714.6220.01--0.170.240.280.440.46
Net Cash / Debt-10.28-5.37-2.5092.9555.0315.363.165.582.112.83
Assets10.1113.3323.4898.8161.2320.377.448.804.825.69
Liabilities24.5521.6658.681143.232.341.821.351.671.51
Book Value-14.45-8.33-35.20-15.4658.0018.035.627.453.154.18
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Neovasc Inc.
Country Canada
Employees 110
CEO Fredericus Antonius Colen

Stock Information

Ticker Symbol NVCN
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: NVCN

Description

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.